8-K
filed June 16, 2026, 4:15 PM ET
ticker INTS
CIK 0001567264
other material
confidence high
sentiment neutral
materiality 0.15
Intensity Therapeutics stockholders elect directors, approve equity plan amendments at annual meeting
INTENSITY THERAPEUTICS, INC.
- Elected Dr. Emer Leahy and Lewis H. Bender as Class III directors with ~416,613 and ~422,149 votes for, respectively.
- Ratified EisnerAmper LLP as auditor for FY 2026 with 1,024,971 votes for, 4,852 against.
- Approved amendment to 2021 Stock Incentive Plan to increase shares by 150,000 (363,563 for, 69,252 against).
- Approved amendment to 2024 ESPP to increase shares by 25,000 (407,404 for, 25,350 against).
- Adjournment proposal passed with 939,304 votes for, 126,814 against.
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
INTENSITY THERAPEUTICS, INC. shareholders approved Approval of amendment to 2024 Employee Stock Purchase Plan to increase shares available by 25,000 at the 2026-06-16 meeting.
- Proposal
- equity plan
- Outcome
- passed
- Meeting
- 2026-06-16
Exact text from the filing
For Against Abstain Broker Non-Votes 407,404 25,350 3,324 643,416
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
INTENSITY THERAPEUTICS, INC. shareholders approved Ratification of selection of EisnerAmper LLP as independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-06-16 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2026-06-16
Exact text from the filing
For Against Abstain 1,024,971 4,852 49,671
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
INTENSITY THERAPEUTICS, INC. shareholders approved Approval of any postponement or adjournment of 2026 annual meeting, if necessary at the 2026-06-16 meeting.
- Outcome
- passed
- Meeting
- 2026-06-16
Exact text from the filing
For Against Abstain 939,304 126,814 13,376
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
INTENSITY THERAPEUTICS, INC. shareholders approved Election of two Class III directors to hold office until the 2029 annual meeting at the 2026-06-16 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2026-06-16
Exact text from the filing
Nominee For Withheld Broker Non-Votes Dr. Emer Leahy 416,613 19,465 643,416 Lewis H. Bender 422,149 13,929 643,416
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
INTENSITY THERAPEUTICS, INC. shareholders approved Approval of amendment to 2021 Stock Incentive Plan to increase shares available by 150,000 at the 2026-06-16 meeting.
- Proposal
- equity plan
- Outcome
- passed
- Meeting
- 2026-06-16
Exact text from the filing
For Against Abstain Broker Non-Votes 363,563 69,252 3,263 643,416
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.